Featured Research

from universities, journals, and other organizations

Two gene mutations drive adrenal cancer

Date:
September 10, 2012
Source:
University of Michigan Health System
Summary:
Two different genetic mutations cooperate to induce adrenal cancer, according to a new study. The finding provides new clues to this rare and deadly cancer type, and researchers hope it will lead to better treatments by targeting both mutations.

Two different genetic mutations cooperate to induce adrenal cancer, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center and University of Sao Paulo in Brazil.

The finding provides new clues to this rare and deadly cancer type, and researchers hope it will lead to better treatments by targeting both mutations.

About 600 Americans are diagnosed with adrenal cancer per year. It is typically diagnosed in late stages when there is nearly no chance of survival beyond five years.

"Because adrenal cancer is so rare, it has been challenging to find enough patients who can provide tissue samples for research. Only through collaboration can we do this," says senior study author Gary Hammer, M.D., Ph.D., the Millie Schembechler Professor of Adrenal Cancer at the University of Michigan Comprehensive Cancer Center.

The partnership between U-M and Sao Paulo has allowed researchers to collect tissue samples from 118 people with benign or cancerous adrenal tumors.

"Our goal is to understand these tumors and the genes that are critical lynchpins so that we can develop treatments that extend patients' lives," Hammer says.

By studying both benign and cancerous adrenal tissue samples, the researchers found aberrations in two genetic pathways: beta-catenin and insulin-like growth factor 2, or IGF-2. The benign tumors had a high percentage of mutations in beta-catenin, but IGF2 up-regulation was rare. On the other hand, most of the adrenal cancers exhibited IGF-2 up-regulation. Cancers that also had beta-catenin mutation were associated with high-grade disease and worse survival, compared to tumors with only IGF-2 up-regulation.

The researchers additionally tested this finding experimentally by inducing individual or combined mutations in beta-catenin and IGF-2 in the mouse adrenal. The mice developed cancer only when both mutations were present.

Results of the study appear in the September issue of the American Journal of Pathology.

The next step is to develop treatments that block both beta-catenin and IGF2.

"It's more complex than just finding genes that cause cancer. Early results targeting IGF2 alone, while promising, don't look as robust as we had initially hoped. That could be because we need to attack both IGF2 and beta-catenin. As cancer treatments move more toward targeted genetic approaches, it's likely that these therapies will need to be used in combination," Hammer says.

Additional authors: Joanne H. Heaton, Michelle A. Wood, Alex C. Kim, Ferdous M. Barlaskar, Rork Kuick, Derek P. Simon, Elisabeth Starnes, Dafydd G. Thomas and Thomas J. Giordano from U-M; Lorena O. Lima, Madson Q. Almeida, Maria C.B.V. Fragoso, Antonio M. Lerario, Ibere C. Soares, and Ana C. Latronico, from Sao Paulo University, Brazil

Funding: U-M Millie Schembechler Adrenal Cancer Research Fund; National Institutes of Health grants DK 062027, CA 134606, T32 DK07245, T32 HD007505, T32 CA009676; National Council for Scientific and Technological Development of Brazil; Coordination for Improvement of Higher Education, Brazil


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Joanne H. Heaton, Michelle A. Wood, Alex C. Kim, Lorena O. Lima, Ferdous M. Barlaskar, Madson Q. Almeida, Maria C.B.V. Fragoso, Rork Kuick, Antonio M. Lerario, Derek P. Simon, Ibere C. Soares, Elisabeth Starnes, Dafydd G. Thomas, Ana C. Latronico, Thomas J. Giordano, Gary D. Hammer. Progression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-Catenin. The American Journal of Pathology, 2012; 181 (3): 1017 DOI: 10.1016/j.ajpath.2012.05.026

Cite This Page:

University of Michigan Health System. "Two gene mutations drive adrenal cancer." ScienceDaily. ScienceDaily, 10 September 2012. <www.sciencedaily.com/releases/2012/09/120910143530.htm>.
University of Michigan Health System. (2012, September 10). Two gene mutations drive adrenal cancer. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2012/09/120910143530.htm
University of Michigan Health System. "Two gene mutations drive adrenal cancer." ScienceDaily. www.sciencedaily.com/releases/2012/09/120910143530.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins